Importantly, differential changes in SLC7A11 (xCT) mRNA levels were validated by RNA-sequencing, further confirming that STAT3/5 signaling is central to the transcriptional regulation of xCT in human breast cancer cells. This evidence concerns the gene SLC7A11 and breast cancer.